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Aims Several factors are known to increase risk for cerebrovascular disease and dementia, but there is limited evidence
on associations between multiple vascular risk factors (VRFs) and detailed aspects of brain macrostructure and
microstructure in large community-dwelling populations across middle and older age.
...................................................................................................................................................................................................
Methods
and results
Associations between VRFs (smoking, hypertension, pulse pressure, diabetes, hypercholesterolaemia, body mass index,
and waist–hip ratio) and brain structural and diffusion MRI markers were examined in UK Biobank (N= 9722, age range
44–79 years). A larger number of VRFs was associated with greater brain atrophy, lower grey matter volume, and
poorer white matter health. Effect sizes were small (brain structural R2 <_1.8%). Higher aggregate vascular risk was
related to multiple regional MRI hallmarks associated with dementia risk: lower frontal and temporal cortical volumes,
lower subcortical volumes, higher white matter hyperintensity volumes, and poorer white matter microstructure in asso-
ciation and thalamic pathways. Smoking pack years, hypertension and diabetes showed the most consistent associations
across all brain measures. Hypercholesterolaemia was not uniquely associated with any MRI marker.
...................................................................................................................................................................................................
Conclusion Higher levels of VRFs were associated with poorer brain health across grey and white matter macrostructure and
microstructure. Effects are mainly additive, converging upon frontal and temporal cortex, subcortical structures,
and specific classes of white matter fibres. Though effect sizes were small, these results emphasize the vulnerability
of brain health to vascular factors even in relatively healthy middle and older age, and the potential to partly ameli-
orate cognitive decline by addressing these malleable risk factors.
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Introduction
With an increasingly ageing population, it is important to understand
the neurobiological underpinnings of age-related cognitive impair-
ment.1–3 The functional sequelae of age-related cerebral decline
carry a high financial, personal, and societal burden, including
impaired daily activities,4,5 predict poorer health, and herald demen-
tia, illness, and death.6 Dementia costs the UK more than £18 billion
per year,7 and around 1% of global gross domestic product in 2010.8
The functional consequences of non-pathological brain ageing (which
are much more prevalent than dementia) impose serious limitations
on independence and quality of life in older age.9,10 Efforts to under-
stand the determinants of cerebral decline and quantify specific brain
effects are urgently needed, especially with respect to modifiable fac-
tors which offer relatively direct pathways to intervention.1,8,10
Neurovascular health is an important correlate of preserved cog-
nition in adult ageing,11,12 yet significant gaps remain in our under-
standing of the links between vascular and cerebral ageing. Cerebral
small vessel disease (CSVD; a constellation of clinical and imaging
findings of presumed vascular aetiology13) causes 45% of dementia
and 20% of stroke worldwide,14 though its pathophysiology and the
interplay among its many possible determinants are not well under-
stood.13 Though the specific mechanisms by which these determi-
nants, often known as vascular risk factors (VRFs), remain to be fully
elucidated, anthropometric indices (waist–hip ratio and body mass
index; WHR and BMI), blood glucose, elevated pulse pressure,
chronic hypertension, diabetes, and hypercholesterolaemia are all pu-
tative VRFs that have been associated with cerebrovascular complica-
tions.15–18 The resultant damage to cerebral vasculature and
increased vascular resistance are thought to deregulate cerebral
blood flow, alongside blood brain barrier dysfunction, and could fur-
ther lead to abnormal protein synthesis and formation of Alzheimer’s
disease-typical plaques and tangles.15,18,19
In community-dwelling samples, the comparative importance of
separate VRFs for the brain in relatively healthy ageing is unclear.
Recent studies have reported brain–heart associations using modern
MRI techniques, identifying areas which modulate sympathetic and
parasympathetic systems.20,21 Large-scale comprehensive research
designs are required to identify specifically which brain biomarkers
are most sensitive to potential VRF effects, yet such data is scarce.
Inconsistencies in the extant literature (e.g. discussed in Ref.22) may
be partly down to low statistical power due to small sample sizes,
and consideration of only one or few measures of risk and/or single
brain MRI outcomes at any one time.22 In non-pathological samples,
effects are likely to be relatively subtle; well-powered, detailed MRI
with multi-tissue analyses which can also account for multiple risk fac-
tors (and their tendency to co-occur) have been called for.23
UK Biobank represents one of the largest general population
cohorts to have collected large-scale brain imaging data alongside in-
formation on VRFs among adults in middle and older age. This study
examines total burden of vascular risk on global and regional meas-
ures of brain grey and white brain matter, derived from structural
and diffusion MRI (dMRI) data in UK Biobank participants. We quan-
tify the unique contributions to global and regional brain structure
made by each simultaneously modelled VRF. The wide age range fur-
ther allows us to test the hypothesis that different VRFs may be more
important for brain structure in midlife than in later life.24–26
Methods
Materials and procedure
When attending the assessment centre for an MRI scan, participants also
provided demographic, health, and socioeconomic information in re-
sponse to a series of touchscreen questions. To improve accuracy, they
also took part in a nurse-led interview about their medical history, which
included any self-reported diagnoses (http://biobank.ctsu.ox.ac.uk/crystal/
field.cgi?id=200). Participants were excluded from the present analysis if
they reported having received a diagnosis of dementia, Parkinson’s dis-
ease or any other chronic degenerative neurological problem (including
demyelinating diseases), brain cancer, brain haemorrhage, brain abscess,
aneurysm, cerebral palsy, encephalitis, head injury, nervous system infec-
tion, head or neurological injury, or trauma, stroke (N= 210). A total of
9722 participants provided brain MRI scan data following exclusions, and
automated and visual quality control (QC) by UK Biobank Imaging group.
Vascular risk factors
During medical history interview at the brain imaging appointment, par-
ticipants also reported whether they had received a diagnosis of diabetes,
hypertension, or hypercholesterolaemia. Data on cigarette smoking were
also available from the touchscreen questionnaire. Blood pressure was
collected twice, moments apart, using an Omron 705IT monitor. Pulse
pressure was calculated as the log-transformed difference between mean
systolic and mean diastolic pressure (or a single measure of each, where
two were unavailable). Anthropometric measures were taken after par-
ticipants had removed bulky clothing and shoes. Waist and hip measure-
ments were conducted to provide WHR, and BMI was calculated as
weight (kg)/height2 (m). For self-reported data, those who preferred not
to answer or did not know were excluded from the analysis in all cases
(<5%).
MRI acquisition and processing
All brain MRI data were acquired on the same 3T Siemens Skyra scanner,
according to a freely available protocol (http://www.fmrib.ox.ac.uk/ukbio
bank/protocol/V4_23092014.pdf), documentation (http://biobank.ctsu.
ox.ac.uk/crystal/docs/brain_mri.pdf), and publication.27 In brief, the data
were acquired with a standard Siemens 32-channel head coil. T1-
weighted MPRAGE and T2-weighted FLAIR volumes were acquired in sa-
gittal orientation at 1 1 1 mm and 1.05 1 1 mm resolution, re-
spectively. The dMRI acquisition comprised a spin-echo echo-planar
sequence with 10 T2-weighted (b 0 s mm-2) baseline volumes,
50 b = 1000 s mm-2 and 50 b = 2000 s mm-2 diffusion weighted volumes,
with 100 distinct diffusion-encoding directions and 2 mm isotropic voxels.
The global tissue volumes, and white matter tract-averaged water mo-
lecular diffusion indices were processed by the UK Biobank team and
made available to approved researchers as imaging-derived phenotypes
(IDPs); the full details of the image processing and QC pipeline are avail-
able in an open access article.27 These included total brain volume, grey
matter volume, white matter hyperintensity (WMH) volume, subcortical
volumes (accumbens, amygdala, caudate, hippocampus, pallidum, puta-
men, thalamus), and tract-averaged fractional anisotropy (FA) and mean
diffusivity (MD) of the following white matter tracts: acoustic radiation,
anterior thalamic, cingulum gyrus, and parahippocampal, corticospinal,
forceps major and minor, inferior fronto-occipital, inferior longitudinal,
middle cerebellar peduncle, medial lemniscus, posterior thalamic, super-
ior longitudinal, superior thalamic, uncinate. Extreme outlying data points
[further than ±4 SD from the mean were excluded case-wise (represent-
ing 0.001% of the total IDP data points analysed]. Figure 1 shows the white
matter tracts and subcortical structures.
Associations between vascular risk factors and brain MRI indices 2291
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In addition to UK Biobank-provided IDPs, we conducted local process-
ing and QC of cortical reconstruction and segmentation, using FreeSurfer
v5.3 on T1-weighted volumes. Following visual inspection of the outputs
(to check for aberrant surfaces and tissue segmentation failures, which
were removed from analysis), a total of 8975 participants had cortical
surfaces available for analysis, 7928 of whom also had casewise
complete vascular, demographic and covariate data, and were used in the
vertex-wise analyses. Surfaces were aligned vertex-wise into common
space (the Freesurfer average template) and smoothed at 20 mm full
width at half maximum, allowing sample-wide analyses of volume across
the cortical mantle.
Analyses
All variables were visually inspected to ascertain whether they were dis-
tributed normally. BMI and WMH were log-transformed to correct a posi-
tively skewed distribution. We subsequently refer to total brain volume
corrected for head size as global atrophy. The ethnicity of the group was
predominantly white, with 203 participants categorizing themselves as
non-white; this dichotomous variable for ethnicity was used as a covariate
in all analyses. Pack years was calculated as the number of cigarettes per
day divided by 20, and then multiplied by the number of years participants
reported having smoked for. A latent measure of general white matter
fractional anisotropy (gFA) and mean diffusivity (gMD) were derived using
confirmatory factor analysis (‘cfa’ in the lavaan package) to index the high
degree of covariance among white matter microstructural properties
across the brain, as previously reported in this cohort28 and in others.29,30.
As described previously,28 all tract measures (left and right) were entered
separately into this analysis, correlated residuals between the left and right
of each tract and between some other tracts were allowed, and based on
low loadings (<0.3) of the Medial Lemniscus, Middle Cerebellar Peduncle
and bilateral Parahippocampal Cingulum on the first factor, these meas-
ures were not included in the factor analysis. Tract loadings and model fit
are shown in Supplementary material online, Table S1.
We used two methods to capture the overall VRF load per individual.
First, we derived an aggregate measure of vascular risk for each individual,
counting instances of a self-reported diagnosis of hypertension, diabetes,
or hypercholesterolaemia, having ever smoked, having a BMI >25,31,32
and having a high WHR (>0.85 for females and >0.90 for males33). We
also derived a latent factor of general vascular risk (gVRF) following prior
work in an older cohort, using confirmatory factor analysis in structural
equation modelling.34 This latent measure captures, and depends upon,
the tendency for VRFs to co-occur. Using ‘cfa’ from the lavaan package,
gVRF was derived from smoking pack years, diastolic and systolic blood
pressure, BMI, WHR, self-reported hypertension, diabetes and hyper-
cholesterolaemia. The model fit the data well, though loadings were in-
consistent (range 0.175–0.758), with the factor more strongly loaded
towards BMI and WHR (see Supplementary material online, Table S2).
First, we conducted descriptive analyses, testing associations between
age and sex with each VRF (pack years, hypertension, pulse pressure, dia-
betes, hypercholesterolaemia, BMI, and WHR) using linear regression
(except for binary VRFs where logistic regression was used). We then
examined associations between global MRI measures (total brain volume,
grey matter volume, WMH, gFA, and gMD) and overall and individual
VRFs. To illustrate the real-terms implications, we conducted a propen-
sity score matching analysis. Individuals with a total of five or six VRFs
were each matched on sex, age, and head size to a single participant who
had no VRFs. We used ‘ps.match’ in the ‘non-random’ package with a logit
Figure 1 White matter tracts-of-interest (left panel) and subcortical structures (right panel) measured in the current study. AR, acoustic radiation;
ATR, anterior thalamic radiation; Cing, cingulum (gyrus and parahippocampal); CST, corticospinal tract; Fmaj and Fmin (forceps major and minor);
IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; MCP, middle cerebellar peduncle; ML, medial lemniscus; PTR, posterior
thalamic radiation; SLF, superior longitudinal fasciculus; STR, superior thalamic radiation; Unc, uncinate fasciculus.
2292 S.R. Cox et al.
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calliper width of 0.05. To optimize group matching, participants were
manually split by sex for matching, and then recombined, after which the
groups were compared on raw volumetric brain indices.
We then tested associations at the regional MRI level. We ran linear
regression analyses to quantify associations between overall load of VRFs
(aggregate and latent VRF variables) and global MRI indices. We also
included all age  VRF interactions; a significant interaction would mean
that there was a difference association magnitude at different ages. In
order to adequately correct our interaction term for the effects of sex,
age, and age2 (i.e. non-linear), we also included sex age and sex age2
as covariate terms.35,36 We also covaried for ethnicity, head size, and dif-
ferences in head positioning inside the scanner (X, Y, and Z co-ordinates;
http://biobank.ctsu.ox.ac.uk/showcase/label.cgi?id=110), which were
mean centred.
Next, we examined associations between each individual VRF and glo-
bal MRI measures. Initially, we ran a separate simple model in which one
VRF predicted each global MRI measure in turn, corrected for age, sex,
ethnicity, head size, and scanner head position. We then re-ran these
models to include a VRF  age interaction term, as described above.
Finally, accounting for the fact that VRFs are positively correlated, we
examined the unique contributions of each VRF to global brain MRI meas-
ures by including all VRFs in one multiple linear regression for each MRI
variable of interest. This approach allowed us to parse the relative contri-
butions of each VRF—in the context of all others—to variance in brain
MRI variables. To quantify the amount of variance in each brain imaging
biomarker accounted for by VRFs, we compared the R2 of each model
with that from a baseline model R2 in which the MRI measure was mod-
elled with covariates only.
We then examined associations between regional MRI measures
(white matter tract-specific FA and MD, vertex-wise cortical volume, and
subcortical volumes) and the latent and aggregate measures of vascular
risk. Finally, we examined the associations between individual VRFs and
regional brain MRI. To do this, we first showed the basic associations for
each individually modelled VRF, before fitting a multiple regression for
each of these regional MRI measures in which all individual VRFs were
entered together. As before, all models also included age, sex, ethnicity,
head size (for volumetric data), and head positioning confounds.
Statistical analyses were performed in R version 3.5.0 (https://www.r-
project.org) except for cortical surface analyses which were performed
using the SurfStat MATLAB toolbox (http://www.math.mcgill.ca/keith/surf
stat) for Matrix Laboratory R2012a (The MathWorks, Inc., Natick, MA,
USA). We ensured that models showed acceptably low multicollinearity
(variance inflation was ascertained using ‘vif’ in the ‘car’ package in R).
Alpha was set at 0.05 for all analyses and results were corrected for mul-
tiple comparisons using the false discovery rate (FDR)37 using ‘p.adjust’
function in the ‘stats’ package in R. Standardized coefficients are reported
throughout to facilitate comparison of associations across all VRFs. The
magnitude of effects can be classified according to Cohen,38 whereby the
effect sizes are small, medium, or large when the standardized coefficients
are 0.1, 0.3, or 0.5, respectively. Maps of the t-statistics for cortical analy-
ses were displayed on the mantle such that negative associations with a
VRF (i.e. lower volume) were always represented by the red end of the
colour spectrum.
Results
Participants were aged between 44.23 and 79.41 (M= 61.97, SD =
7.48) years, and participant characteristics are shown in Table 1. When
modelling each VRF on age, sex, and age  sex (see Supplementary
material online, Table S3), males had significantly higher levels on all risk
factors, and there were significant age sex interactions for pack years
(b ¼ 0.039), pulse pressure (b ¼ 0.049), and aggregate vascular risk
(b ¼ 0.025). There was a significant association between greater vas-
cular risk and older age across all VRFs (b range 0.083–0.498) except
for BMI which showed a weak relationship in the opposite direction (b
= -0.027). Plots of simple VRF trends with age are presented in
Supplementary material online, Figure S1. Consistent with the full UK
Biobank cohort,39 VRFs were generally modestly but significantly cor-
related (see Supplementary material online, Figure S2 and Table S4).
Older age was a relatively strong predictor of greater global atrophy
and WMH volume, lower grey matter volume and gFA, and higher
gMD (see Supplementary material online, Table S4; b range j0.254j to
j0.586j), consistent with prior reports from the initial release of UK
Biobank MRI data (N 500028,40). Sex differences in brain MRI meas-
ures were consistent with those previously described in a smaller UK
Biobank sample.41
Global brain MRI analyses
General vascular risk
Associations between aggregate vascular risk and global MRI meas-
ures are reported in Table 2. Having a larger number of VRFs was
associated with ostensibly ‘poorer’ global brain MRI health across all
measures (b range j0.042j to j0.110j), accounting for1% of the vari-
ance in brain MRI measures beyond the contribution of covariates.
Aside from the modest but significant positive interaction between
age and aggregate VRF on higher gMD (interaction b = 0.036; main
effect b = 0.072; indicating more VRFs are more strongly associated
with less healthy white matter in older age), there was no evidence
that associations between global brain measures and general vascular
risk were stronger at different ages.
The propensity score matching procedure yielded two groups of
235 individuals who were matched on age, sex, and head size (see
Supplementary material online, Table S5). On average, when com-
pared with individuals with no VRFs, individuals with five or six VRFs
had 17 927 mm3 (1.5%) lower brain volume, 17 869 mm3 (2.89%) less
total grey matter, and 1191 mm3 (51.54%) greater WHM burden.
Alongside a measure of aggregate vascular risk, we quantified a la-
tent factor of vascular risk (gVRF34), which showed a good fit to the
data (see Supplementary material online, Figure S2 and Table S2). The
measure of aggregate VRF and gVRF were strongly correlated
(r= 0.795). Whereas gVRF exhibited numerically larger association
magnitudes with all global MRI measures apart from MD (see
Supplementary material online, Table S6), these differences were
modest; however, owing to the large N in the present study, we
could detect that the gVRF associations were significantly larger for
grey matter volume [t(9719) = 3.401, P< 0.001] and WMH volume
[t(8859) = 2.222, P= 0.026].
Individual vascular risk factors
Associations between global brain MRI measures and individual VRFs
are also reported in Table 2. A greater number of pack years smoked,
and a diagnosis of hypertension or diabetes were independently asso-
ciated with putatively poorer global brain structural parameters
(greater global atrophy, lower grey matter volume, more WMH,
lower gFA, and higher gMD; b range j0.022j to j0.104j). Higher BMI
and WHR were both consistently associated with greater global
Associations between vascular risk factors and brain MRI indices 2293
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..atrophy, lower grey matter volume and higher WMH load, but both
were non-significant for gFA, and only WHR was associated with
higher gMD. Higher pulse pressure was associated with poorer white
matter measures (higher WMH and MD, and lower FA), but was also
related to less global atrophy (b= 0.24). Finally, a diagnosis of hyper-
cholesterolaemia was only significantly associated with greater WMH
load, but with no other MRI index. No significant interactions were
found between individual VRFs and global brain measures (see
Supplementary material online, Table S7), and so age  VRF interac-
tions were not further investigated at the brain regional level.
Simultaneous modelling of individual VRF-global brain associations
indicated that the contributions of VRFs were mostly independent.
Overall, magnitudes of associations between VRFs and global MRI
variables were modest, explaining a small amount of additional vari-
ance beyond covariates. In order of smallest to largest, the incremen-
tal R2 explained by all VRFs was: global atrophy = 0.004, gFA = 0.011,
grey matter volume = 0.011, gMD = 0.015, WMH = 0.018 (Table 2).
The numerically largest associations were for hypertension on white
matter measures (b range j0.080j to j0.094j), whereas self-reported
hypercholesterolaemia did not make any significant unique contribu-
tion—above other VRFs—to any global MRI measure (b<_ 0.007).
The most notable effect of simultaneously modelling VRFs was that,
whereas WHR still showed significant associations with global volu-
metric MRI measures (global atrophy, grey matter volume, and
WMH volume), the magnitude was attenuated by 50%, and BMI
was no longer significantly associated with any MRI measure except
grey matter volume. This, however, indicates that variance in both
BMI and WHR made unique contributions to lower grey matter vol-
umes. Pack years, hypertension, pulse pressure, and diabetes were
still most consistently linked across all global brain outcomes.
Regional brain MRI analyses
General vascular risk
We tested whether there was regional specificity underlying the glo-
bal MRI associations between general and specific vascular risk.
Vertex-wise cortical analysis revealed widespread significant associa-
tions between higher aggregate vascular risk and lower cortical vol-
ume (Figure 2). The FDR-corrected q-map illustrates the comparative
sparing of dorsal motor/somatosensory and posterior cortical
regions, while the t-map indicates largest effect sizes in the frontal
and especially anterior lateral and medial temporal lobes.
Results of the associations of aggregate vascular risk with white matter
tract FA and MD, and with subcortical volumes are shown in Figure 2 and
Supplementary material online, Table S8. Higher aggregate vascular risk
was associated with lower FA and higher MD and particularly implicated
association and thalamic fibres. Unexpectedly, we also found some asso-
ciations with projection fibres which were numerically among the largest
magnitudes but in the opposite direction; higher aggregate risk was asso-
ciated with higher FA in the corticospinal tract (b = 0.052), and middle
cerebellar peduncle (b = 0.065), and also with lower MD in the medial
lemniscus (b = -0.060). Higher aggregate vascular risk was also associ-
ated with generally lower subcortical volumes in all structures (b range
-0.087 to -0.046) except the amygdala (b¼ -0.006).
....................................................................................................................................................................................................................
Table 1 Participant characteristics
Variable Units Descriptor N
Demographics
Age Years M (SD) 61.97 (7.48) 9722
Sex F (%F) 5105 (52.51) 9722
Ethnicity White British (%) 9519 (98) 9722
VRFs
Smokera,m Current:Ex:Never 399:3322:5910 9631
Pack years Years M (SD) 4.76 (11.11) 9631
Hypertensiona,m Yes (Yes%) 2002 (20.59) 9722
Pulse pressurea,m mm Hg M (SD) 57.03 (13.39) 9346
Diabetesa,m Yes (Yes%) 476 (5.90) 9722
Hypercholesterolaemiaa,m Yes (Yes%) 1069 (11.00) 9722
BMIa,m Kg/m2 median (IQR) 26.08 (5.36) 9693
WHRa,m W:H M (SD) 0.86 (0.08) 9695
Brain MRI
Total brain volume mm3 M (SD) 1 166 776 (110 729.90) 9722
Grey matter volume mm3 M (SD) 615 142.30 (55 039.46) 9722
WMH volume mm3 median (IQR) 2147.00 (3007.00) 8861
gFA Std units M (SD) 0 (1) 8601
gMD Std units M (SD) 0 (1) 8514
Heart or cardiac problem includes self-report of angina. Brain MRI volumes are raw values (uncorrected for head size). Significant positive association between greater vascular
risk and aage, and m/fgender (see Supplementary material online, Table S3).
BMI, body mass index; VRF, vascular risk factor; WHR, waist–hip ratio; WMH, white matter hyperintensity, gFA and gMD (latent factors of white matter fractional anisotropy
and mean diffusivity).
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..The corresponding analysis for gVRF showed an almost identical
pattern for cortical, white matter and subcortical measures (see
Supplementary material online, Figure S3 and Table S9), though associ-
ation magnitudes were, on average, slightly stronger throughout. For
the vertex-wise analysis, this resulted in slightly higher t-values which
were significant across slightly less restricted cortical loci, and was
also the case for subcortical values.
Individual vascular risk factors
The patterning of significant associations of each individually
modelled VRF across the brain’s cortex are shown in Figure 3. All
FDR-corrected (q) significant associations were in the expected dir-
ection (higher VRF with lower volume). Pulse pressure and hyper-
cholesterolaemia showed no FDR-corrected significant associations
with the cortex (see Supplementary material online, Figure S4). For
pack years, hypertension, diabetes, BMI, and WHR, a consistent pat-
tern of associations emerged where the strongest effects in each case
were in the lateral and medial temporal lobes. As with overall vascu-
lar risk, cortical associations towards the vertex were consistently ab-
sent. Medial and lateral frontal areas also showed significant
associations, and relationships with occipital regions were most evi-
dent for smoking and diabetes.
Simultaneous modelling of individual VRFs across the cortex
revealed the extent to which each VRF made a unique contribution
to variance in regional volume, accounting for all other VRFs (see
Supplementary material online, Figure S5). Though effect sizes were
generally weaker, and the FDR-corrected loci were more restricted
than when individually modelled, the patterning of associations was
largely unaltered. The common and unique patterns were more for-
mally compared in the conjunction and conditional cortical analyses
(see Supplementary material online, Figure S6). This emphasizes clear-
ly that (i) individual VRFs make unique contributions to lower cortical
volume at specific—common—foci: medial and anterior frontal, and
temporal cortex, and (ii) there were also regions which showed no
overlap, indicating VRF-specific associations.
Associations between individually modelled VRFs and white mat-
ter tract microstructure are reported in Figure 4 and Supplementary
material online, Tables S10 and S11. Thalamic and association fibres
and the forceps minor showed the most consistent associations with
lower FA and higher MD. These were driven by hypertension, pulse
pressure, diabetes, and pack years (b range j0.023j to j0.106j), in con-
trast to BMI and WHR whose associations were more consistent
across projection bundles. Hypercholesterolaemia was not signifi-
cantly associated with FA or MD in any tract.
............................. ......................... ........................ ......................... .........................
....................................................................................................................................................................................................................
....................................................................................................................................................................................................................
Table 2 Associations between individually and simultaneously modelled vascular risk factors on global brain MRI
parameters
Vascular Global atrophy GM WMH gFA gMD
risk factors Model b P B P b P b P b P
Aggregate VRF – 20.061 <0.001 20.097 <0.001 0.110 <0.001 20.042 <0.001 0.072 <0.001
 Age – 0.005 0.607 -0.002 0.785 -0.014 0.163 -0.019 0.093 0.036 <0.001
Additional R2 0.005 0.008 0.010 0.002 0.007
Total R2 0.344 0.474 0.321 0.099 0.184
Pack years Single 20.037 <0.001 20.061 <0.001 0.076 <0.001 20.036 <0.001 0.044 <0.001
Simultaneous 20.029 <0.001 20.046 <0.001 0.062 <0.001 20.033 0.002 0.036 <0.001
Hypertension Single 20.027 0.001 20.037 <0.001 0.097 <0.001 20.084 <0.001 0.104 <0.001
Simultaneous 20.022 0.012 20.022 0.006 0.080 <0.001 20.084 <0.001 0.094 <0.001
Pulse pressure Single 0.024 0.008 0.013 0.122 0.069 <0.001 20.044 <0.001 0.074 <0.001
Simultaneous 0.033 <0.001 0.024 0.004 0.053 <0.001 20.033 0.005 0.058 <0.001
Diabetes Single 20.044 <0.001 20.066 <0.001 0.065 <0.001 -0.037 <0.001 0.045 <0.001
Simultaneous 20.037 <0.001 20.050 <0.001 0.038 <0.001 -0.022 0.041 0.028 0.007
High cholesterol Single -0.003 0.712 -0.006 0.434 0.023 0.009 -0.007 0.520 0.016 0.099
Simultaneous 0.007 0.402 0.001 0.200 0.003 0.788 0.004 0.693 0.001 0.909
BMI Single 20.037 <0.001 20.078 <0.001 0.053 <0.001 0.003 0.749 0.013 0.209
Simultaneous -0.012 0.240 20.043 <0.001 0.003 0.790 0.026 0.041 -0.028 0.022
WHR Single 20.060 <0.001 20.101 <0.001 0.082 <0.001 -0.000 0.981 0.041 0.002
Simultaneous 20.036 0.007 20.050 <0.001 0.048 <0.001 0.007 0.685 0.027 0.086
VRF added R2 0.004 0.011 0.018 0.011 0.015
Total R2 0.343 0.476 0.325 0.106 0.185
Standardized betas (b) and P-values are reported from regression models where VRFs are regressed onto MRI measures, covarying for ethnicity, sex, age, sex  age, and head
position MRI confounds (volumetric data are also corrected for head size). Model denotes the results for each VRF modelled individually, and then when modelled simultan-
eously alongside all other VRFs. Additional R2 refers to the amount of variance in MRI measures accounted for by the simultaneously modelled VRFs, beyond covariates. Bold
text denotes FDR q-value <0.05.
BMI, body mass index; GM, grey matter volume; VRF, vascular risk factor; WHR, waist–hip ratio; WMH, white matter hyperintensity, gFA and gMD (latent factors of white mat-
ter fractional anisotropy and mean diffusivity).
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Associations between subcortical volumes and VRFs are
reported in Figure 4 and Supplementary material online, Table
S12. The majority of VRFs were significantly associated with
lower volumes of all subcortical structures (b range j0.024j to
j0.085j) except for the amygdala. However, hypercholesterol-
aemia was only associated with lower accumbens (b = -0.028)
and thalamus volumes (b = -0.019), and pulse pressure showed
no significant associations at all. Simultaneously modelling all
VRFs for each tract (see Supplementary material online, Tables
S13 and S14) and subcortical volume (see Supplementary mater-
ial online, Table S15) did not substantially change this pattern of
results, suggesting that effects are mainly independent from each
other. However, high cholesterol was no longer significantly
related to any subcortical volume.
Discussion
Interpretation
In this large, single-scanner sample of middle- and older-aged adults,
associations between greater vascular risk and poorer brain health
were small but significant across cortical, white matter, and subcor-
tical tissue; there was a dose effect whereby the magnitude of associ-
ation increased with the number of VRFs. Notably, individuals with
the highest levels of VRF burden had, on average, 50% greater WMH
burden than those with no VRFs who were matched on age, sex, and
head size (though there was considerable group overlap).
Associations between vascular risk and brain structure did not differ
appreciably across the sampled age range. We also provide insight
into the relative contributions of different VRFs to brain health:
greater pack years, a diagnosis of hypertension and diabetes each
made unique contributions to poorer brain health across grey matter
and WMH volume, white matter microstructure, and subcortical vol-
ume. Conversely, pulse pressure was mainly related to white but not
grey matter measures, whereas WHR was only uniquely associated
with volumetric grey and WMH (but not microstructure). A diagno-
sis of hypercholesterolaemia made no unique contributions to brain
health beyond other risk factors.
Throughout, effect sizes were mainly small according to Cohen,38
accounting for less than 2% of the variance in brain structure. By pro-
viding very accurate estimates of effect sizes in this very large sample,
we provide guidance to researchers and clinicians on the range of
effects to plausibly expect in designing future studies and interven-
tions. The presence of significant associations between vascular fac-
tors and brain health in this relatively healthy sample (which was of
the same magnitude, irrespective of age) has implications for the po-
tential for the management of malleable VRFs—among those of com-
paratively good health, and even in middle age—to improve and
brain and cognitive ageing.
Our results provide further evidence for regional cerebral vulner-
ability to VRFs in healthy individuals. On the cortex, associations be-
tween aggregate vascular risk and lower cortical volume shows
Figure 2 Associations between aggregate vascular risk and cortical volume (left panel), white matter tract-specific microstructure (centre panel
showing right lateral and superior views), and subcortical volume (right panel showing, from top to bottom: anterior, lateral, and inferior views).
Higher aggregate vascular risk is associated with significantly lower cortical volume, lower fractional anisotropy and higher mean diffusivity in the ma-
jority of white matter fibres, and lower subcortical volume, except for the amygdala (grey).
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Figure 3 Significant associations (left: t-maps and right: FDR-corrected q-values) between cortical volume and vascular risk factors (modelled indi-
vidually, alongside age, sex, ethnicity, head size, and scanner head position confounds). See Supplementary material online, Figure S3 for non-significant
associations for pulse pressure and hypercholesterolaemia. T-maps are scaled with the same limits to aid comparison of relative effect size across risk
factors.
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strongest effects on frontal and especially anterior lateral and medial
temporal lobes, rather than dorsal motor/somatosensory and pos-
terior cortical regions. The cortical patterning in this large healthy
sample is more extensive than the areas associated with cardiac regu-
lation,20,21 agrees with loci associated with other markers of CSVD in
community-dwelling adults,42,43 and is strikingly consistent with the
regional ischaemic vulnerability of the brain to hypoperfusion in clin-
ical samples44 and the pattern of atrophy common in ‘typical’
Alzheimer’s disease.45
We find that greater vascular risk is related to ‘poorer’ white mat-
ter microstructure (higher MD and lower FA) in specific classes of
white matter tract. The association and thalamic radiations along
with the forceps minor showed the most consistent significant rela-
tionships with vascular risk. These pathways also appear most sus-
ceptible to ageing, and we had previously hypothesized that this
susceptibility and the phenomenon of age-related (statistical)
de-differentiation might be partly driven by the disproportionately
negative effects of environmental factors on these same fibres.28 This
also concurs with an explanation that these fibres connect the most
metabolically active regions of the brain46 and may be at greatest risk
of neurovascular ageing.15,19,44 Finally, higher vascular risk was related
to modestly lower subcortical volumes across the accumbens, caud-
ate, hippocampus, pallidum, putamen, and thalamus. Subcortical atro-
phy and WMH burden are also related to clinical diagnoses of
dementia and vascular cognitive impairment.47
As far as we are aware, this is the largest single-scanner study of
multiple VRFs and multi-modal structural brain imaging to-date. The
high statistical power allowed us to reliably detect subtle and non-
overlapping contributions of multiple individual VRFs to a large var-
iety of brain health markers. Though there is some tendency for
VRFs to co-occur, our simultaneous modelling indicated that smok-
ing, hypertension, pulse pressure, diabetes, and WHR each made
unique statistical contributions to lower global brain and higher
WMH volumes. Whereas it is possible that associations between
obesity and brain structure are partly attributable to the findings that
obesity promotes arterial stiffness, it is possible that the unique statis-
tical contributions identified herein could pertain to other mecha-
nisms through which body composition is linked to negative brain
and cognitive endpoints, including metabolic and endocrine routes,
which may have independent neurovascular consequences.17,26,48
Similarly, the unique contributions to brain structure made by hyper-
tension and smoking may indicate that the deleterious effects of
smoking on the brain extend beyond putative alterations in hyperten-
sion.49 This adds to the literature on the complex interplay between
multiple sources of vascular risk and their associations with brain
health.
Limitations
The age range does not cover older ages (upper age limit was
79 years), restricting the degree to which our findings can be general-
ized to other populations. This may also have limited our scope to
identify age–VRF interactions; such effects may be driven by very
small associations in individuals who are much older than participants
included here.25 The UK Biobank imaging sample shows a tendency
to live in less deprived areas than other UK Biobank participants,50
who are already range restricted compared with the general popula-
tion,51 which may limit generalizability. Nevertheless, it is striking that
associations between VRFs and brain structure are detectable even
in these relatively healthy individuals, and effects may be larger in a
more population-representative sample. These data are cross-
sectional, and cannot speak to lifelong trends in vascular risk, trajecto-
ries of brain regional decline nor important aspects such as lead-lag
effects. Though we made attempts to remove individuals with neuro-
logical or neurodegenerative disorders, it is not possible to ascertain
the degree to which the results reported here are driven by individu-
als with nascent age-related clinical neurodegenerative conditions.
Figure 4 Standardized betas of associations between individually
modelled vascular risk factors and white matter tract fractional an-
isotropy (top panel), white matter tract mean diffusivity (centre
panel), and subcortical volumes (bottom panel). Acc, accumbens;
Amyg, amygdala; ATR, anterior thalamic radiation; BP, hypertension;
Caud, caudate; Cing, cingulum (gyrus and parahippocampal); CST,
corticospinal tract; Diab, diabetes; Fmaj and Fmin (forceps major
and minor); HiChol, hypercholesterolaemia. AR, acoustic radiation;
Hipp, hippocampus; IFOF, inferior fronto-occipital fasciculus; ILF, in-
ferior longitudinal fasciculus; MCP, middle cerebellar peduncle; ML,
medial lemniscus; Pall, pallidum; PP, pulse pressure; PTR, posterior
thalamic radiation; Put, putamen; SLF, superior longitudinal fascic-
ulus; STR, superior thalamic radiation; Thal, thalamus; Unc, uncinate
fasciculus.
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However, the lack of VRF  age interactions might militate against a
substantial confound.
The VRFs themselves represent different levels of fidelity—hyper-
tension, diabetes, and hypercholesterolaemia were binary rather
than continuous measures, and all were based on self-report (albeit
via a medical interview with a nurse). As a consequence, it is possible
that individual variability on continuous measures (such as blood
cholesterol, or HbA1c) would prove more informative for brain out-
comes. However, this alone cannot explain the null hypercholester-
olaemia associations, given the results for diabetes and hypertension.
Though the simultaneous modelling of individual VRFs did not funda-
mentally alter the pattern of simple main effect, the combination of
dichotomous and continuous variables could mean that any attenua-
tions of estimates (from individual models) could partly be driven by
this limitation, and should be interpreted with appropriate caution.
On a related note, efficacy, dosage, and time since diagnosis are all
pertinent factors not measured here. These and other vascular risk
markers may well interact with differences in genetic susceptibility to
determine brain and cognitive outcomes (e.g.52,53), and is a priority
for future study.
Whereas the imaging acquisition and variety of sequences acquired
can be considered state-of-the-art, the limitations of dMRI, and of
assuming that higher FA and lower MD automatically relate to
‘poorer’ white matter microstructure or health, should be observed.
There are many microstructural (including myelination, axonal bore,
crossing fibres) and methodological factors that influence measure-
ment of water molecular diffusion, necessitating a more nuanced in-
terpretation.54 This is evident in the conflicting directions of
association between projection fibres compared with callosal, thal-
amic, and association tracts. Taking the example of the middle cere-
bellar peduncle (which showed positive FA and MD betas)—in
complex fibre structures with multiple crossing pathways, one can
envisage a situation where FA and MD are positively correlated when
more degraded transecting fibres provide less interference to mo-
lecular diffusion along the principal direction of the tract, thus leading
to increases in both the directional coherence and the overall magni-
tude of water molecular diffusion.
Summary
Elevated vascular risk in this large group of community-dwelling
adults from the general population was related to poorer brain
health. A larger accumulation of VRFs increased the magnitude of the
association. The patterning of these effects was most pronounced in
areas linked to elevated stroke and hypoperfusion susceptibility, and
typical Alzheimer’s disease atrophy, and in the white matter pathways
that facilitate their connectivity. Smoking, diabetes, and hypertension
showed the most consistent associations across global and regional
brain measures.
Supplementary material
Supplementary material is available at European Heart Journal online.
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